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The aim of this study is to analyze whether melatonin administration inﬂuenced the nuclear factor-kappa B (NF-κB) activity,
proinﬂammatory cytokines expression, and oxidative response in the basilar artery after SAH. A total of 48 rabbits were randomly
divided into four groups: control group, SAH group, SAH + vehicle group, and SAH + melatonin group. All SAH animals were
subjected to injection of autologous blood into cisterna magna twice on day 0 and day 2. The melatonin was administered
intraperitoneally at a dose of 5mg/kg/12h simultaneously with SAH from day 0 to day 5. The basilar arteries were extracted
on day 5 after SAH. As a result, we found that vascular inﬂammation and oxidative stress were induced in all SAH animals.
In animals given melatonin, basilar arterial NF-κB and pro-inﬂammatory cytokines were decreased in comparison to vehicle-
treated animals. Measures of oxidative stress also showed signiﬁcant downregulation after melatonin treatment. Furthermore,
administration of melatonin prevented vasospasm on day 5 following SAH. In conclusion, post-SAH melatonin administration
may attenuate inﬂammatory response and oxidative stress in the spasmodic artery, and this may be one mechanism involved in
the therapeutic eﬀect of melatonin on the subsequent vasospasm after SAH.
Copyright © 2009 Qi Fang et al. This is an open access article distributed under the Creative Commons AttributionLicense, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Cerebral vasospasm is the most common cause of dis-
ability and death in patients suﬀering from aneurysmal
subarachnoid hemorrhage (SAH) [1]. Cerebral vasospasm
is commonly caused by the presence of blood products,
especially oxyhemoglobin (OxyHb) in the subarachnoid
space. Even though the trigger role of OxyHb in the devel-
oping vasospasm is well known, the exact mechanism(s)
of vasospasm is still unknown. The possible mechanisms
mayinclude:upregulatedvascularinﬂammation,endothelial
apoptosis, increased free radical products and oxidative
stress, adenosine diphosphate- (ADP-) induced vasomotor
changes, inhibition of nitric oxide (NO) pathway, pro-
tein kinase C (PKC) pathway in vascular smooth muscle,
among which inﬂammation and oxidative stress both play
important roles in the pathological process of vasospasm
[2–4].
Recently, several studies on experimental models of SAH
have demonstrated that melatonin can prevent vasospasm
[5–7]; however, the exact mechanism of vasoprotective eﬀect
is still unknown. As mentioned by Ersahin et al., treatment
with melatonin due to its free radical scavenging properties
signiﬁcantly inhibited SAH-induced lipid peroxidation and
neutrophil inﬁltration of the brain tissue on the second day
of SAH induction in rats. However till now, no study was
found in the literature to investigate the eﬀects of melatonin
on vascular inﬂammatory response and oxidative stress after
SAH.
There is increasing evidence that inﬂammation is critical
in the development of cerebral vasospasm [8]. Nuclear
factor-κB( N F - κB) and proinﬂammatory cytokines, such as
tumor necrosis factor α (TNF-α), interleukin (IL)-1β,a n d
IL-6, may be key factors contributing to the inﬂammation in
spasmodicarteries[9].Oxidativestressisastateofimbalance
between free radical production, particularly the reactive2 Mediators of Inﬂammation
oxygen species (ROS) leading to progressive oxidative dam-
age, and the ability of the organism to defend itself against
them. Usually, ROS can be eﬃciently scavenged by the
antioxidant defense system such as superoxide dismutase
(SOD) and glutathione peroxidase(GSH-Px). Malondialde-
hyde (MDA) is the end product of the major reactions
leadingtosigniﬁcantoxidationofpolyunsaturatedfattyacids
i nc e l l u l a rm e m b r a n e s ,a n dt h u si ts e rv e sa sar e l i a b l em a r k e r
of oxidative stress [10]. Thus, the aim of the current study
was to determine whether melatonin could regulate the level
of inﬂammatory agents and biomarkers of oxidative stress in
the basilar artery after experimental SAH in rabbits.
2.MaterialsandMethods
2.1. Animals. The animal use and care protocols, including
all operation procedures, were approved by the Animal Care
and Use Committee of Soochow University and conformed
to the Guide for the Care and Use of Laboratory Animals
by the National Institute of Health. Forty-eight adult male
New Zealand White (NZW) rabbits weighing from 2.2 to
2.8kgwerepurchasedfromtheAnimalCenteroftheChinese
Academy of Sciences (Shanghai, China). They were accli-
matedinahumidiﬁed roomandmaintainedonthestandard
pellet diet at the Animal Center of Soochow University for
10 days before the experiment. The temperature in both the
feeding room and the operation room was maintained at
about 25◦C.
2.2. Two-Hemorrhage Rabbit Model. Experimental SAH was
produced according to our previous study [11]. The rabbits
were anesthetized with an intramuscular injection of a
mixture of ketamine (25mg/kg) and droperidol (1.0mg/kg)
on day 0. Under spontaneous breathing, a 23-gauge butterﬂy
needle was inserted percutaneously into the cisterna magna.
After withdrawal of 1.5mL CSF, the same amount of
nonheparinizedfreshautologousauriculararterialbloodwas
slowly injected into the cisterna magna for 1 minute under
aseptic technique. Then animals were kept in a 30◦ head-
down position for 30 minutes, which made blood ﬂow from
the cisterna magna to the basilar cistern more easily and
quickly. After recovery from anesthesia, they were returned
to the feeding room. Forty-eight hours after the ﬁrst SAH, a
second one was produced in the same manner as the ﬁrst.
In control animals, the same technique was applied with
injection of sterile saline instead of blood.
2.3. Experimental Design. The experimental groups con-
sisted of control group (n = 12), SAH group (n = 12),
SAH+vehicle group (n = 12), and SAH+melatonin (n =
12). In the animals of SAH+melatonin group, melatonin
(5mg/kg) was administered immediately after ﬁrst blood
injection and was continued every 12 hours for 120 hours.
Rabbits of SAH+vehicle group received equal volumes
of vehicle (1% ethanol in 1mL saline) at corresponding
time points. Both melatonin and vehicle were administered
intraperitoneally. Melatonin (Sigma, St Louis, MO, USA)
was dissolved in absolute ethanol and further dilutions
were made in saline to reach a ﬁnal concentration of 1%
(v/v) ethanol. The dose was chosen according to Aydin and
coworkers since they observed beneﬁcial eﬀects on reducing
the vasoconstriction of the basilar artery following SAH after
treatment with melatonin using the same dose [5]. All the
rabbits were killed on day 5.
Six rabbits in each group were sacriﬁced with the
ﬁxation-perfusion method. The basilar arteries were taken
for hematoxylin and eosin (H&E) staining. The other six
rabbits in each group were exsanguinated and decollated.
The artery was removed and rinsed in 0.9% normal saline
(4◦C) several times to wash away blood and blood clot. And
then the artery was frozen in liquid nitrogen immediately for
biochemical studies.
2.4.Perfusion-Fixation. Therabbitsscheduledfordeathwere
anesthetized with an intramuscular injection of a mixture
of ketamine (40mg/kg) and droperidol (2.5mg/kg). The
animals were then intubated endotracheally with a 3.5mm
diameter tracheal tube and mechanically ventilated with a
rodent ventilator (SGC, China). Perfusion-ﬁxation was then
performed. The thorax was opened with a cannula placed
in the left ventricle, the descending thoracic aorta clamped,
and the right atrium open. Perfusion was begun with 500mL
of physiological phosphate buﬀer solution (PBS, pH 7.4) at
37◦C, followed by 500mL of 10% buﬀered formaldehyde
under a perfusion pressure of 120cm H2O. After perfusion-
ﬁxation, the whole brain with the basilar artery was removed
and immersed in the same ﬁxative solution.
2.5. Measurement of Blood Vessel Cross-Sectional Area. The
degree of cerebral vasospasm was evaluated by the mea-
surement of basilar artery lumen’s cross-sectional areas. The
formalin-ﬁxedandparaﬃn-embeddedbasilararterysections
(4μm in thickness) were deparaﬃnized, hydrated, washed,
and stained with hematoxylin and eosin. Then micrographs
of the basilar arteries were put into the computer. Cross-
sectional areas and wall thicknesses of blood vessels were
determined by an investigator without knowing the group
setting, using the High Deﬁnition Medical Image Analysis
Program (HMIAP-2000, developed by Tongji Medical Uni-
versity, China). The areas were calculated by measuring the
perimeter of the actual vessel lumen and then calculating
the area of an equivalent circle (area=πr2,w h e r er =
radius) based on the calculated equivalent r value from the
perimeter measurement (r = perimeter/2π), thus correcting
for vessel deformation and oﬀ-transverse sections. For each
vessel, three sequential sections (midpoint of the proximal,
the middle, and the distal) were taken, measured, and
averaged.
2.6. Nuclear Protein Extract and Electrophoretic Mobility Shift
Assay(EMSA). Nuclearproteinwasextractedandquantiﬁed
as described [12]. EMSA was performed using a commercial
kit (Gel Shift Assay System; Promega, Madison, WI) fol-
lowing the methods in our laboratory. The NF-κB oligonu-
cleotide probe (5 -AGTTGAGGGGACTTTCCCAGGC-3 )
was end-labeled with [γ-32P]ATP (Free Biotech, Beijing,Mediators of Inﬂammation 3
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Figure 1: Changes in the cross-sectional area of basilar arteries
in the experimental SAH model. (a)–(d) Representative images of
cross-sectional areas of the basilar arteries of the control rabbits or
rabbits subjected to SAH alone or SAH plus injection with vehicle
or melatonin. Severe vasospasm could be detected in the SAH
group,whichwasattenuatedintheSAH+melatoningroup.(a)The
control group; (b) the SAH group; (c) the SAH+vehicle group; (d)
the SAH+melatonin group; (e): Histogram of the average cross-
sectional area of the basilar arteries from diﬀerent groups. There
is a signiﬁcant diﬀerence in the basilar artery cross-sectional area
between the SAH and control groups. The basilar artery cross-
sectional area was signiﬁcantly increased in the SAH+melatonin
group compared with the SAH or SAH+vehicle groups. Results are
represented as means± SD of six rabbits in each group. ∗∗P<. 01
versus control group, ns P>. 05 versus SAH group; ##P<. 05 versus
SAH+vehicle group.
China). EMSA was performed according to our previous
study [12]. After electrophoresis, the gel was transferred to
Whatman ﬁlter paper, vacuum dried and exposed to Kodak
XAR-5 ﬁlm overnight. Levels of NF-κB DNA binding activity
were quantiﬁed by scanning the developed Kodak XAR-5
ﬁlm with a computer-assisted, linear scanning densitometer
in transparent mode (Hoefer Scientiﬁc Instruments, San
Francisco, CA). Data were expressed as arbitrary densit-
ometry units (ADUs) obtained from the densitometric
scans.
2.7. Enzyme-Linked Immunosorbent Assay (ELISA). The lev-
els of inﬂammatory mediators were quantiﬁed using speciﬁc
ELISA kits for rats according to the manufacturers’ instruc-
tions (TNF-α from Diaclone Research, Besanc ¸on, France;
IL-1β, IL-6 from Biosource Europe SA, Nivelles, Belgium)
and our previous study [12]. Values were expressed as ng/g
protein.
2.8. Measurement of MDA Levels. MDA levels were deter-
mined with the method of the previous studies [13, 14].
The principle of the assay depends on the reaction of
lipid peroxidation products with thiobarbituric acid and
formation of products named as thiobarbituric acid reacting
substances, which give maximum absorbance at 532nm
wavelength. Serial dilutions of 1,1,3,3 tetraethoxypropane
were used to obtain a standard absorbance versus concen-
tration curve, and MDA concentrations of the tissue samples
were determined from this curve. MDA concentrations were
given as nmol/g wet tissue.
2.9. Measurement of Tissue SOD Activities. SOD enzyme
activities were determined with RANSOD (Randox, UK)
SOD assay kit. The method of the assay employs xanthine
and XOD to generate superoxide radicals which react with
INT to form a red formazan dye. The SOD activity is then
measured by the degree of inhibition of the reaction. One
unit of SOD is that which causes a 50% inhibition of the rate
of reduction of INT under the conditions of the assay. SOD
activities of the samples were given as U/mg protein.
2.10. Measurement of Tissue GSH-Px Activities. GSH-Px
Assay (Northwest Life Science Specialities Vancouver, WA,
USA) kit was used for the determination of tissue GSH-Px
activities and this assay is an adaptation of the method of
previous studies [14, 15]. The principle of the assay is as
follows: GSH-Px catalyzes the reduction of H2O2, oxidizing
reduced GSH to form GSSG. GSSG is then reduced by GR
and β-nicotinamide denine dinucleotide phosphate forming
NADP+ (resulting in decreased absorbance at 340nm) and
recycling the GSH. Because GSH-Px is limiting, the decrease
in absorbance at 340nm is directly proportional to the GSH-
Px concentration. GSH-Px activity is reported as units based
on the deﬁnition: 1U of GSH-Px= the amount of enzyme
necessary to catalyze the oxidation (by H2O2)o f1 . 0 μmol
G S Ht oG S S Gp e rm i n u t ea t2 5 ◦C, pH 7.0. GSH-Px activities
of the tissue samples were given as units per milligram of
protein.
2.11. Statistical Analysis. All data were presented as mean ±
SD. SPSS 12.0 was used for statistical analysis of the data. All
dataweresubjectedtoone-wayANOVA.Diﬀerencesbetween
experimental groups were determined by the Fisher’s LSD
posttest. Statistical signiﬁcance was inferred at P<. 05.4 Mediators of Inﬂammation
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Figure 2: NF-κB activity in the basilar arteries in control group
(n = 6), SAH group (n = 6), SAH+vehicle group (n = 6), and
SAH+melatonin group (n = 6). (a) EMSA autoradiography of NF-
κB DNA binding following SAH. (b) Levels of NF-κB DNA binding
activity quantiﬁed by computer-assisted densitometric scanning
and expressed as an arbitrary densitometric units (ADUs). The
activity of NF-κB DNA binding was signiﬁcantly increased in the
animals of SAH and SAH+vehicle groups compared with the
control group (P<. 01). Compared to SAH or SAH+vehicle
group, melatonin signiﬁcantly suppressed NF-κB activation in
SAH+vehicle group (P<. 01). Bars represent the mean ± SD.
∗∗P<. 01 compared with control group, ns P>. 05 compared with
SAH group; ##P<. 01 compared with SAH+vehicle group.
3. Results
3.1. General Observation. No signiﬁcant changes in body
weight, mean arterial blood pressure, temperature, or
injected arterial blood gas data were detected in any of
the experimental groups (data not shown). The rabbits all
survived from the procedure of induction of experimental
SAH.
3.2. Melatonin Administration Ameliorated Cerebral Vasos-
pasmafterSAH. AsshowninFigure 1,therewasasigniﬁcant
diﬀerence in the cross-sectional area of basilar artery among
all the groups on day 5 following SAH (P<. 01).
A signiﬁcant diﬀerence was detected between the SAH
(211745.2 ± 19158.4μm2) and the control (416253.4 ±
32508.4μm2)g r o u p s( P<. 01) (Figure 1). There was also
a signiﬁcant diﬀerence in the basilar arterial cross-sectional
areabetweentheSAH+melatonin(372806.5±31195.3μm2)
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Figure 3:Changesofinﬂammatorymediatorsinthebasilararteries
as determined by ELISA in control group (n = 6), SAH group
(n = 6), SAH+vehicle group (n = 6), and SAH+melatonin
group (n = 6). SAH could induce the signiﬁcantly increased
concentrations of IL-1β,T N F - α, and IL-6 in rabbit vascular tissue.
In SAH+melatonin group, the arterial concentrations of IL-1β,
TNF-α, and IL-6 were markedly downregulated as compared with
that of SAH or SAH+vehicle group. ∗P<. 05 and ∗∗P<. 01 versus
Control group, ns P>. 05 versus SAH group, #P<. 05 and ##P<. 01
versus SAH+vehicle group.
and SAH+vehicle (213345.6 ± 12213.5μm2)g r o u p s( P<
.01) (Figure 1). No signiﬁcant diﬀerence was seen between
the SAH group and the SAH+vehicle group (P>. 05).
3.3. Eﬀects of Melatonin on NF-κB Binding Activity in SAH
Basilar Arteries. To determine the inﬂuence of melatonin
on NF-κB binding activity in the basilar arteries post SAH,
EMSA was performed to detect the changes of NF-κB
as described in Section 2. EMSA autoradiography of NF-
κB DNA binding activity of in the basilar arteries was
shown in Figure 2.L o wN F - κB binding activity (weak EMSA
autoradiography)wasfoundinthecontrolgroup.Compared
with the control group, NF-κB binding activity in the artery
wassigniﬁcantlyincreased(P<. 01)inSAHorSAH+vehicle
group on day 5 after SAH. There was no statistically signiﬁ-
cantdiﬀerencebetweenSAHgroupandSAH+vehiclegroup
(P>. 05) (Figure 2). In SAH+melatonin group, arterial NF-
κBbindingactivitywassigniﬁcantlydownregulated(P<. 01)
after melatonin injections.
3.4. Melatonin Treatment Decreased Vascular Levels of Proin-
ﬂammatory Cytokines following SAH. Concentrations of IL-
1β,T N F - α, and IL-6 were low in the basilar arteries of
the control group (3.35 ± 0.43, 0.28 ± 0.07, and 0.18 ±
0.01ng/g protein, resp.) (Figure 3). Compared with Control
group, vascular levels of the three inﬂammatory cytokines
were greatly induced in SAH or SAH+vehicle group. As
shown in Figure 3, melatonin administration after SAH
could lead to signiﬁcantly decreased IL-1β,T N F - α and IL-
6 concentrations. The result showed that melatonin admin-
istration following SAH could downregulate the expressions
of Proinﬂammatory cytokines in the basilar arteries.Mediators of Inﬂammation 5
Table 1: Vascular antioxidant status of the experimental group of animals.
Groups n MDA (nmol/g) SOD (U/mg) GSH-Px (U/mg)
Control 6 31.28 ±8.27 0.52 ±0.11 .08 ±0.21
SAH 6 48.12 ±6.13∗ 0.21 ±0.08∗ 0.72 ±0.16∗
SAH+vehicle 6 46.21 ±5.07ns 0.22 ±0.11ns 0.76 ±0.08ns
SAH+melatonin 6 38.07 ±7.1# 0.43 ±0.12## 1.02 ±0.31#
Inthetable,arterialMDAconcentrationsweregivenpergramofwettissue;SOD,GSH-Pxenzymaticactivitiesweregivenpermg/protein.Valuesareexpressed
as mean± SD. (∗P<. 05 and ∗∗P<. 01 versus Control group, ns P>. 05 versus SAH group, #P<. 05 and ##P<. 01 versus SAH+vehicle group).
3.5. Inﬂuence of Melatonin on Oxidative Stress in the Basilar
Arteries after SAH. T h ev a l u e so ft h et i s s u eM D Al e v e l sa n d
tissue SOD and GSH-Px enzyme activities were shown in
Table 1. SAH signiﬁcantly increased the tissue MDA levels
(P<. 05) and signiﬁcantly decreased the tissue SOD and
GSH-Px enzyme activities (P<. 05) when compared with
controls.Melatonintreatmenthasshownprotectiveeﬀectvia
decreasing signiﬁcantly (P<. 05) the elevated MDA levels
and also signiﬁcantly increasing the reduced antioxidant
enzyme activities (SOD, P<. 01; GSH-Px, P<. 05).
4. Discussion
The main ﬁndings of this study are that (1) vascular inﬂam-
matory mediators were induced after SAH and could be
remarkably repressed when treated with melatonin; (2) the
increasedlipidperoxidationinthearterytissuescouldbesig-
niﬁcantly downregulated after melatonin injections follow-
ing experimental SAH; (3) after melatonin administration,
the postSAH reduced antioxidative status was ameliorated
in this two-hemorrhage model; (4) in agreement with the
previous research [5], treatment with melatonin prevented
cerebral vasospasm of the basilar arteries in rabbits. These
ﬁndings suggest for the ﬁrst time that melatonin could
regulate vascular inﬂammation and oxidative stress, and this
may be one mechanism by which melatonin attenuates the
development of cerebral vasospasm after SAH.
There have been many studies focusing on the neurovas-
cular protective eﬀects of melatonin in SAH models [5–7,
16].Mostofthesepreviousstudiesusedtheone-hemorrhage
SAH model; however in the current research, we used the
two-hemorrhage model that was more suitable for SAH-
cerebral vasospasm research than one-hemorrhage model
because the time course of vasospasm accurately correlates
with that observed in humans, which peaked on day 5 after
SAH [17]. Thus, in the present study, we chose day 5 as the
research time-point. Also, we gave melatonin after the onset
of hemorrhage, which matches the clinical setting.
In the circumstance of SAH, a complex series of cellular
and molecular events is elicited by the presence of a blood
clot in the subarachnoid space, culminating in a robust
inﬂammatory response. Following cellular and molecular
events were involved: (1) expressions of adhesion molecules
that evoke leukocytes adhesion to the endothelium; (2)
cytokines production; (3) immunoglobulin and comple-
ment activation. Cerebral vasospasm might result from
the interaction among those events [8]. During the whole
physiopathologic process of cerebral vasospasm, NF-κBa n d
Proinﬂammatory cytokines played important roles [9].
In the research regarding melatonin and inﬂammatory
mediators, Alonso et al. investigated the eﬀects of melatonin
on the expressions of inducible nitric oxide synthase (iNOS)
and NF-κB in rat skeletal muscle after acute exercise [18].
Their results indicated that melatonin had potent protective
eﬀects against damage caused by acute exercise in rat muscle,
preventing oxidative stress, NF-κB activation, and iNOS
over-expression. At the same time, the results from another
previous study showed that melatonin exhibited a superior
capacity to reduce the Proinﬂammatory cytokines (IL-1β,
IL-6, and TNF-α) in amyloid-beta-induced oxidative stress
model [19]. However, data was still scarce concerning the
eﬀects of melatonin on the vascular inﬂammation in SAH
models. In the present study, we conﬁrmed that SAH could
activate the inﬂammatory mediators such as NF-κB, IL-1β,
IL-6, and TNF-α, which has been reported in the previous
studies [8, 9]. Furthermore, we put forward that mela-
tonin treatment could suppress the vascular inﬂammatory
response in this rabbit SAH model.
Excessive production of free radicals and subsequent
lipid peroxidation has been suggested causally related to
cerebral vasospasm after SAH [6, 20]. There are several
sources for the excessive generation of free radicals fol-
lowing SAH, including disrupted mitochondrial respiration
and extracellular hemoglobin but the principal origin in
vasospasm is thought to be the autooxidation of oxyhe-
moglobin to methemoglobin, which leads to production
of superoxide radical [6]. Antioxidant agents such as 1,2-
bis(nicotinamide)-propane, tirilazad, resveratrol, and ebse-
len have been shown to ameliorate experimental vasospasm
and reduce lipid peroxidation in some diﬀerent animal
models [6]. upregulation of free radical producing enzymes
and inhibition of intrinsic antioxidant systems such as SOD
and GSH-Px occurs after SAH and leads the brain to
oxidative damage [6]. As revealed by Ersahin [7], treatment
with melatonin due to its free radical scavenging properties
signiﬁcantly inhibited SAH-induced lipid peroxidation and
neutrophil inﬁltration of the brain tissue on the second
day of SAH induction, while the depleted antioxidant GSH
level and inhibited Na+-K+-ATPase activity were restored
to control levels. However, for the vascular tissues, the
eﬀect of melatonin on oxidative stress following SAH still
remains unknown. Our data demonstrated that treatment
with melatonin induced the antioxidant defense system,
downregulated lipid peroxidation in the basilar artery, and6 Mediators of Inﬂammation
resulted in a signiﬁcant increase of the cross-sectional area
of basilar artery after SAH. Therefore, our results suggested
the possibility of a vascular oxidation preventive function of
melatonin administration following experimental SAH.
In summary, to the best of our knowledge, this is
the ﬁrst study to demonstrate the eﬀects of melatonin on
inﬂammation and oxidative stress in the cerebral artery after
SAH. We found that SAH could upregulate the inﬂamma-
tory mediators, increase lipid peroxidation, and inhibit the
antioxidant defense system in the rabbit basilar artery, which
could be markedly modulated by melatonin administration.
The treatment of melatonin in this SAH model resulted
in attenuation the degree of cerebral vasospasm following
SAH. These results suggest that SAH could induce vascular
inﬂammatory process and oxidative stress in the arterial
wall which might play a central role in the pathogenesis
of cerebral vasospasm. The therapeutic beneﬁt of postSAH
melatonin administration might be due to its salutary eﬀect
on modulating Proinﬂammatory mediators and biomarkers
of oxidative stress.
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